Principal Technologies' Successful Financing Event
Principal Technologies Inc. (TSXV: PTEC) has recently accomplished a significant milestone in its financial journey by successfully completing a non-brokered private placement. This initiative marks an important step in the company's growth strategy and commitment to advancing its healthcare technology endeavors.
Details of the Private Placement
In the private placement, Principal Technologies issued 2,080,000 common shares, generating an impressive total of $624,000 in funding. The shares were sold at a price of $0.30 each, reflecting a strong interest from investors in the company’s future prospects. This financing is intended to fuel the company's ongoing research and development projects linked to its License of Technology Agreement with Oxford University Innovation Limited.
Utilization of the Proceeds
The funds raised through this private placement will be earmarked to support Principal Technologies' research and development commitments under their licensing agreement as well as general corporate purposes. The decision to forgo finder’s fees demonstrates the company's strong belief in its potential and commitment to maximizing shareholder value.
Understanding the Implications of the Share Offering
The shares acquired in this offering are subject to a statutory hold period, which expires four months post-issuance, following Canadian securities regulations. The completion of this private placement is still conditional upon final acceptance by the TSX Venture Exchange. Principal Technologies is optimistic that this approval will progress smoothly.
Related Party Participation
A notable aspect of this private placement involves participation from Roman Leydolf, a significant shareholder of Principal Technologies. His investment underscores insider confidence in the company's direction and growth potential. This transaction qualifies as a related party transaction under Multilateral Instrument 61-101, which aims to protect minority shareholders in special transactions.
About Principal Technologies Inc.
Principal Technologies Inc. is dedicated to improving healthcare through innovation. The company focuses on acquiring and growing a portfolio of healthcare technology firms that possess global distribution capabilities and innovative intellectual property aimed at enhancing the quality of medical treatments and improving patient care pathways. Their mission revolves around implementing technologies that optimize health outcomes while maintaining cost efficiency.
Conclusion
The successful closure of this private placement highlights Principal Technologies Inc.'s commitment to innovation and advancement within the healthcare sector. With significant funds secured to propel their projects forward, the company is poised for an exciting phase of growth, enhancing their technological capabilities and refining their contributions to the healthcare industry.
Frequently Asked Questions
What funding amount did Principal Technologies raise in the placement?
Principal Technologies raised $624,000 through this private placement.
What was the price per share in the private placement?
The shares were priced at $0.30 each in the private placement.
Who was the significant shareholder involved in the private placement?
Roman Leydolf, a significant shareholder, participated in the financing.
What is the purpose of the funds raised?
The funds will be used for research and development related to the technology licensing agreement and other corporate purposes.
Which exchange is Principal Technologies listed on?
Principal Technologies is listed on the TSX Venture Exchange under the ticker symbol PTEC.
